EUVIMEDEUVIMED entdecken
Crossref

Unnecessary spending by health care entities on unproven COVID-19 treatments in the United States from January 2020 to December 2022

Christopher A Schriever, Surrey M Walton, Kasem Barakat, Glen T Schumock

Journal of the American Pharmacists Association · 2026-11 · 103608

DOI: 10.1016/j.japh.2026.103608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-11. Verfasst von Christopher A Schriever und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Associate Professor, Section of Infectious Diseases Pharmacotherapy, University of Illinois Chicago, Herbert M. and Carol H. Retzky College ….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19drug expenditurespandemicsocial media

Autor:innen und Institutionen

  • Clinical Associate Professor, Section of Infectious Diseases Pharmacotherapy, University of Illinois Chicago, Herbert M. and Carol H. Retzky College of Pharmacy, Rockford, IL. Electronic address: cschri1@uic.edu.
  • Professor, Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Herbert M. and Carol H. Retzky College of Pharmacy, Chicago, IL. Electronic address: walton@uic.edu.
  • University of Illinois Chicago, Herbert M. and Carol H. Retzky College of Pharmacy, Chicago, IL. Electronic address: kbara4@uic.edu.
  • Dean, Herbert M. and Carol H. Retzky College of Pharmacy, Professor, Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Herbert M. and Carol H. Retzky College of Pharmacy, Chicago, IL. Electronic add…

Zitieren

APA

Schriever, C. A., Walton, S. M., Barakat, K., & Schumock, G. T. (2026). Unnecessary spending by health care entities on unproven COVID-19 treatments in the United States from January 2020 to December 2022. Journal of the American Pharmacists Association, 103608. https://doi.org/10.1016/j.japh.2026.103608

Vancouver

Schriever CA, Walton SM, Barakat K, Schumock GT. Unnecessary spending by health care entities on unproven COVID-19 treatments in the United States from January 2020 to December 2022. Journal of the American Pharmacists Association. 2026:103608. doi:10.1016/j.japh.2026.103608

BibTeX
@article{Schriever2026,
  author = {Schriever, Christopher A and Walton, Surrey M and Barakat, Kasem and Schumock, Glen T},
  title = {Unnecessary spending by health care entities on unproven COVID-19 treatments in the United States from January 2020 to December 2022},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  pages = {103608},
  doi = {10.1016/j.japh.2026.103608}
}
Kostenlos starten →